• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ProPhase Labs Inc

+ Add to Watchlist

PRPH:US

1.4900 USD 0.0200 1.36%

As of 20:10:00 ET on 12/26/2014.

Snapshot for ProPhase Labs Inc (PRPH)

Open: 1.5000 Day's Range: 1.4400 - 1.5000 Volume: 1,711
Previous Close: 1.4700 52wk Range: 1.2100 - 2.9800 1-Yr Rtn: -10.24%

Stock Chart for PRPH

No chart data available.
  • PRPH:US 1.4900
  • 1D
  • 1M
  • 1Y
1.4700
Interactive PRPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRPH

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1800
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 23.04
Shares Outstanding (M) 15.46
30 Day Average Volume 12,991
Price/Book (mrq) 2.1865
Price/Sale (ttm) 1.0903
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRPH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PRPH

ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The Company's products reduce the duration and severity of common cold symptoms. ProPhase also manufactures nutrition and weight management products.

Ted KarkusChairman/CEORobert V Cuddihy JrExec VP/CFO/COO
More Company Profile & Key Executives for PRPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil